| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.097 | 0.03 |